Multidrug-resistant tuberculosis in children: Evidence from global surveillance

European Respiratory Journal

Volumn 42, Issue 3, 2013, Pages 701-707

  Zignol, Matteo ^a   Sismanidis, Charalambos ^a   Falzon, Dennis ^a   Glaziou, Philippe ^a   Dara, Masoud ^a   Floyd, Katherine ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL STRAIN; BELGIUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SURVEILLANCE PROGRAM; FEMALE; GERMANY; HUMAN; LATVIA; MAJOR CLINICAL STUDY; MALE; MOLDOVA; MULTIDRUG RESISTANT TUBERCULOSIS; NAMIBIA; NORWAY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOUTH AFRICA; SWEDEN; UNITED KINGDOM; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; ISONIAZID; LOGISTIC MODELS; MALE; ODDS RATIO; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION;

EID: 84883538547     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00175812     Document Type: Article

References (30)

1. World Health Organization. Global Tuberculosis Report 2012. Geneva, WHO Press, 2012.
2. Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
3. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on MDR-TB outcomes. Eur Respir J 2013; 42: 156-168.
4. Marais BJ, Schaaf HS. Childhood tuberculosis: an emerging and previously neglected problem. Infect Dis Clin North Am 2010; 24: 727-749.
5. Seddon JA, Hesseling AC, Willemse M, et al. Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome. Clin Infect Dis 2012; 54: 157-166.
6. Hwang TJ, Ottmani S, Uplekar M. A rapid assessment of prevailing policies on tuberculosis contact investigation. Int J Tuberc Lung Dis 2011; 15: 1620-1623.
7. Hill PC, Ota MO. Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases. Lancet Infect Dis 2010; 10: 723-732.
8. Schaaf HS, Marais BJ, Hesseling AC, et al. Childhood drug-resistant tuberculosis in the Western Cape Province of South Africa. Acta Paediatr 2006; 95: 523-528. (Pubitemid 43791572)
9. Schaaf HS, Marais BJ, Hesseling AC, et al. Surveillance of antituberculosis drug resistance among children from the Western Cape Province of South Africa - an upward trend. Am J Public Health 2009; 99: 1486-1490.
10. Kassa-Kelembho E, Bobossi-Serengbe G, Takeng EC, et al. Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Int J Tuberc Lung Dis 2004; 8: 574-578. (Pubitemid 38625062)
11. Fairlie L, Beylis NC, Reubenson G, et al. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis 2011; 11: 28.
12. Zignol M, van Gemert W, Falzon D, et al. Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010. Bull World Health Organ 2012; 90: 111D-119D.
13. Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009; 373: 1861-1873.
14. World Health Organization. Guidelines for Surveillance of Drug Resistance in Tuberculosis. 4th Edn. Publication number: WHO/HTM/TB/2009.422. Geneva, WHO Press, 2009.
15. Zignol M, van Gemert W, Falzon D, et al. Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing. Clin Infect Dis 2011; 52: 901-906.
16. World Health Organization. Multidrug and Extensively Drug-resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response. Publication number: WHO/HTM/TB/2009.422 Geneva, WHO, 2010.
17. World Health Organization. TB Data. www.who.int/tb/country/data/download/ en/index.html Date last accessed: November 1, 2012. Date last updated: November 1, 2012.
18. Swaminathan S, Datta M, Radhamani MP, et al. A profile of bacteriologically confirmed pulmonary tuberculosis in children. Indian Pediatr 2008; 45: 743-747.
19. Schaaf HS, Vermeulen HA, Gie RP, et al. Evaluation of young children in household contact with adult multidrug-resistant pulmonary tuberculosis cases. Pediatr Infect Dis J 1999; 18: 494-500. (Pubitemid 29277611)
20. Steiner M, Cosio A. Primary tuberculosis in children. 1. Incidence of primary drug-resistant disease in 332 children observed between the years 1961 and 1964 at the Kings County Medical Center of Brooklyn. N Engl J Med 1966; 274: 755-759.
21. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363: 1005-1015.
22. Nicol MP, Workman L, Isaacs W, et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011; 11: 819-824.
23. Rachow A, Clowes P, Saathoff E, et al. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 2012; 54: 1388-1396.
24. Tuberculosis in the UK. London, Health Protection Agency, 2011. www.hpa.org.uk/webc/HPAwebFile/HPAweb-C/1317131791612 Date last accessed: November 1, 2012. Date last updated: December 2011.
25. Dara M, de Colombani P, Petrova-Benedict R, et al. The minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement. Eur Respir J 2012; 40: 1081-1090.
26. Moore M, Onorato IM, McCray E, et al. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA 1997; 278: 833-837. (Pubitemid 27383373)
27. European Centre for Disease Prevention and Control/World Health Organization Regional Office for Europe. Tuberculosis Surveillance and Monitoring in Europe 2012. Stockholm, European Centre for Disease Prevention and Control, 2012.
28. Ettehad D, Schaaf HS, Seddon JA, et al. Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12: 449-456.
29. Becerra MC, Appleton SC, Franke MF, et al. Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. Lancet 2011; 377: 147-152.
30. Schaaf HS, Marais BJ. Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians. Paediatr Respir Rev 2011; 12: 31-38.